Login

HIG Capital spends £25 million on Cambridge life sciences hub

Investment part of group's high-growth European push
HIG Capital has bought in Cambridge. (Keith Yates/CoStar)
HIG Capital has bought in Cambridge. (Keith Yates/CoStar)
CoStar News
January 22, 2025 | 9:56 AM

HIG Capital, an alternative investment firm with $67 billion (£54.51 billion) of capital under management, has acquired a Cambridge innovation campus with plans to turn it into a world-class life sciences facility.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE